Annual report 2018

54 | Galenica annual report 2018 Members of the Board of Directors Corporate Governance Fritz Hirsbrunner, elected since 2017 – Born 1949, Swiss citizen – Lic. oec., HEC University of Lausanne/Senior Executive Program, IMD, Lausanne – 1972–1977 Controller at Ciba-Geigy – Joined the former Galenica Group in 1977 as Assistant to the Corporate Executive Committee; member of the Corporate Executive Committee from 1992 to 2011; Deputy CEO and CFO. Head Investor Relations from 2012 to 2014 (mandate basis) – Member of the Board of Trustees of IST Investmentstiftung für Personal­ vorsorge (Zurich) – Member of the Board of Directors of Berlac AG (Sissach), IVF Hartmann Holding AG (Neuhausen), Ven-Cap 6 Ltd. (Jersey) and Vifor Pharma Ltd. (St. Gallen) Dr. Jörg Kneubühler, Chairman of the Board of Directors, elected since 2017 – Born 1960, Swiss citizen – Dr. rer. pol., University of Bern – Held various positions in finance at the Swatch Group before joining Galenica – Joined the former Galenica Group in 2002 as Head of Finance and Administra- tion at Vifor Pharma; Head of Controlling for the Galenica Group as of 2006; Head Corporate Finance and Controlling for the Galenica Group and member of the Corporate Executive Committee from 2009; CFO from 2012 to 2016; and CEO Galenica Santé from 2014 to Q1 2017 Prof. Dr. Michel Burnier, elected since 2017 – Born 1953, Swiss citizen – Swiss-registered Doctor of Internal Medicine and Nephrology – Honorary professor, University of Lausanne – Member of the Swiss Society of Nephrology (former President), European Society of Hypertension (council member and Treasurer) and Swiss Society of Hypertension (former President) – Formerly a member of the Medicines Committee of the Swiss Association of Pharmacists (until 2001) and the Board of Swissmedic (2002–2010) – Member of the Board of Directors of Speedel Holding Ltd. (Basel) from 2007 to 2009 – Member of the Board of Directors of Vifor Pharma Ltd. (St. Gallen) Daniela Bosshardt-Hengartner, elected since 2017 – Born 1972, Swiss citizen – Pharmacist, Federal Diploma in Pharmacy, Federal Institute of Technology, Zurich (ETHZ) – Financial analyst at Bank am Bellevue (1998–2002) and M2 Capital (2003–2004) – Management consultant in the pharmaceutical, medical technology and biotechnology sectors since 2004 – Member of the Board of Directors of Rep-Risk AG (Zurich), Vifor Pharma Ltd. (St. Gallen) and investiere.ch (Baar) Galenica